模拟降低注射剂量对淀粉样蛋白PET扫描评估的影响
研究纳入认知受损与未受损个体共250例(36%为Aβ阳性),分别注射[18F]氟比他班或[18F]氟贝他苯,通过列表模式采集并模拟75%、50%、25%、12.5%和5%原始注射剂量图像,评估定量与定性分析。结果显示5%剂量时SUVR变化分别为3.72%和3.12%,Centiloid绝对变化为3.35CL和4.62CL;12.5%剂量时SUVR百分比变化和Centiloid绝对变化均小于1.5%,各剂量水平AUC≥0.94,视觉评估读者内一致性均超过80%。结论认为两种示踪剂在12.5%原始注射剂量下可获得足够的定量与定性评估。
要点
- 12.5%剂量下[18F]氟比他班和[18F]氟贝他苯的SUVR百分比变化与Centiloid绝对变化均小于1.5%。
- 各剂量水平区分Aβ阴性与阳性扫描的AUC≥0.94,视觉评估读者内一致性均超过80%。
- 5%剂量时两种示踪剂SUVR变化分别为3.72%和3.12%,Centiloid绝对变化为3.35CL和4.62CL。
核心结论
- 这项概念验证研究显示,[18F]氟比他班和[18F]氟贝他苯在原始注射剂量的12.5%时即可获得足够的定量和定性评估。
- 但降低注射剂量的决定应结合具体临床或研究情况来做出。
研究设计与样本
- 研究纳入认知受损与未受损个体共250例(36%为Aβ阳性),其中175例注射[18F]氟比他班,75例注射[18F]氟贝他苯。
- 注射后90–110分钟以列表模式采集PET扫描,并模拟生成原始注射剂量75%、50%、25%、12.5%和5%的图像。
- 图像使用厂家提供的重建工具重建后进行Aβ病理视觉评估,并以小脑皮质为参考组织计算全局皮质和三个较小区域的SUVR及Centiloid。
主要发现
- 5%注射剂量时,[18F]氟比他班的SUVR变化为3.72%、Centiloid绝对变化为3.35CL;[18F]氟贝他苯的SUVR变化为3.12%、Centiloid绝对变化为4.62CL。
- 12.5%注射剂量时,SUVR百分比变化和Centiloid绝对变化均小于1.5%。
- 各剂量水平区分Aβ阴性与Aβ阳性扫描的AUC均较高(AUC≥0.94)。
- 两种示踪剂的视觉评估读者内一致性均超过80%。
关键数值与推荐
- 以SUVR百分比变化和Centiloid绝对变化评估定量差异。
- 以ROC分析评估区分Aβ阴性与Aβ阳性扫描的能力,AUC≥0.94。
- 以读者内一致性评估视觉判读,两种示踪剂均超过80%。
局限性
- 本研究为概念验证研究。
- 降低注射剂量的决定应结合具体临床或研究情况来做出。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the impact of reduced injected doses on the quantitative and qualitative assessment of the amyloid PET tracers [18F]flutemetamol and [18F]florbetaben. METHODS: Cognitively impaired and unimpaired individuals (N = 250, 36% Aβ-positive) were included and injected with [18F]flutemetamol (N = 175) or [18F]florbetaben (N = 75). PET scans were acquired in list-mode (90-110 min post-injection) and reduced-dose images were simulated to generate images of 75, 50, 25, 12.5 and 5% of the original injected dose. Images were reconstructed using vendor-provided reconstruction tools and visually assessed for Aβ-pathology. SUVRs were calculated for a global cortical and three smaller regions using a cerebellar cortex reference tissue, and Centiloid was computed. Absolute and percentage differences in SUVR and CL were calculated between dose levels, and the ability to discriminate between Aβ- and Aβ + scans was evaluated using ROC analyses. Finally, intra-reader agreement between the reduced dose and 100% images was evaluated. RESULTS: At 5% injected dose, change in SUVR was 3.72% and 3.12%, with absolute change in Centiloid 3.35CL and 4.62CL, for [18F]flutemetamol and [18F]florbetaben, respectively. At 12.5% injected dose, percentage change in SUVR and absolute change in Centiloid were < 1.5%. AUCs for discriminating Aβ- from Aβ + scans were high (AUC ≥ 0.94) across dose levels, and visual assessment showed intra-reader agreement of > 80% for both tracers. CONCLUSION: This proof-of-concept study showed that for both [18F]flutemetamol and [18F]florbetaben, adequate quantitative and qualitative assessments can be obtained at 12.5% of the original injected dose. However, decisions to reduce the injected dose should be made considering the specific clinical or research circumstances.
引用
- Young P, Heeman F, Axelsson J, et al. Impact of simulated reduced injected dose on the assessment of amyloid PET scans. Eur J Nucl Med Mol Imaging. 2023. PMID: 37897616. doi:10.1007/s00259-023-06481-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。